Taxol- and okadaic acid-induced destabilization of bcl-2 mRNA is associated with decreased binding of proteins to a bcl-2 instability element

Biochemical Pharmacology

Volumn 66, Issue 7, 2003, Pages 1151-1162

  Bandyopadhyay, Sumita ^a   Sengupta, Tapas K ^a   Fernandes, Daniel J ^a   Spicer, Eleanor K ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bcl 2 gene expression; Leukemia; mRNA instability element; mRNA stability; Okadaic acid; Taxol

Indexed keywords

CELL EXTRACT; MESSENGER RNA; OKADAIC ACID; PACLITAXEL; PROTEIN; PROTEIN ARE 1; PROTEIN BCL 2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DNA CROSS LINKING; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY;

EID: 0141852376     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00453-2     Document Type: Article

References (36)

1. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
2. Cleary M.L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:1986;19-28.
3. Reed J.C. Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Adv. Pharmacol. 41:1997a;501-532.
4. Campos L., Rouault J.-P., Sabido O., Oriol P., Roubi N., Vasselon C., Archimbaud E., Magaud J.-P., Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 81:1993;3091-3096.
5. Reed J.C. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Sem. Hemat. 34:1997b;9-19.
6. 1 phase-dependent expression of Bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells. Mol. Pharmacol. 58:2000;1001-1010.
7. Liu Y., Priest D.G. Enhancement of Bcl-2 mRNA degradation by taxol and other anticancer drugs that induce apoptotic cell death. Cell. Pharmacol. 3:1996;405-408.
8. Riordan F.S., Foroni L., Hoffbrand V., Mehta A.B., Wickremasinghe R.G. Okadaic acid-induced apoptosis of HL-60 leukemia cells is preceded by destabilization of bcl-2 mRNA and downregulation of bcl-2 protein. FEBS Lett. 435:1998;195-198.
9. Shaw G., Kamen R. A conserved AU sequence from the untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
10. Stoecklin G., Hahn S., Moroni C. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Biol. Chem. 269:1994;28591-28597.
11. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell. 42:1985;889-902.
12. Schiavi S.C., Belasco J.G., Greenberg M.E. Regulation of proto-oncogene mRNA stability. Biochim. Biophys. Acta. 1114:1992;95-106.
13. Chen C.-Y.A., Shyu A.-B. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:1995;465-470.
14. Xu N., Chen C.Y., Shyu A.B. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell Biol. 17:1997;4611-4621.
15. Schiavone N., Rosini P., Quattrone A., Donnini M., Lapucci A., Citti L., Bevilacqua A., Nicolin A., Capaccioli S. A conserved AU-rich element in the 3′ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J. 14:2000;174-184.
16. Shyu A.-B., Greenberg M.E., Belasco J.G. The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways. Genes Dev. 3:1989;60-72.
17. Wisdom R., Lee W. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:1991;232-243.
18. Donnini N., Lapucci A., Papucci L., Witort E., Tempestini A., Brewer G., Bevilacqua M., Nicolin A., Capaccioli S., Schiavone N. Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins. Biochem. Biophys. Res. Commun. 287:2001;1063-1069.
19. Lapucci A., Donnini M., Papucci L., Witort E., Tempestini A., Bevilacqua M., Nicolin A., Brewer G., Schiavone N. Capaccioli, AUF1 is a bcl-2 A + U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis. J. Biol. Chem. 277:2002;16139-16146.
20. Steube K.G., Jadau A., Teepe D., Drexler H.G. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines. Leukemia. 9:1995;1841-1846.
21. Tsujimoto Y., Croce C.M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. U.S.A. 83:1986;5214-5218.
22. Chen C.-Y., Chen T.-M., Shyu A.-B. Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function. Mol. Cell Biol. 14:1994;416-426.
23. Ford L.P., Wilusz J. An in vitro system using HeLa cytoplasmic extracts that reproduces regulated mRNA stability. Methods. 17:1999;21-27.
24. Ma W.J., Cheng S., Campbell C., Wright A., Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed elav-like protein. J. Biol. Chem. 271:1996;8144-8151.
25. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
26. Altschul S.F., Madden T.L., Schaffer A.A., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
27. 2AR-binding protein and is obligate for agonist-induced destabilization of receptor mRNA. J. Biol. Chem. 272:1997;11471-11478.
28. Zubiaga A.M., Belasco J.G., Greenberg M.E. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell. Biol. 15:1995;2219-2230.
29. Chen C.-Y., Shyu A.-B. Selective degradation of early-response-gene mRNAs: functional analyses of sequence features of the AU-rich elements. Mol. Cell Biol. 14:1995;8471-8482.
30. Levy N.S., Chung S., Furneaux H., Levy A.P. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 173:1998;6417-6423.
31. Wang W., Furneaux H., Cheng H., Caldwell M.C., Hutter D., Liu Y., Holbrook N., Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol. Cell Biol. 20:2000a;760-769.
32. Wang W., Caldwell M.C., Lin S., Furneaux H., Gorospe M. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 19:2000b;1-12.
33. Dean J.L.E., Wait R., Mahtani K.R., Sully G., Clark A.R., Saklatvala J. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell Biol. 21:2001;721-730.
34. Fan X.C., Steitz J.A. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:1998;3448-3460.
35. Shyu A.-B., Belasco J.G., Greenberg M.E. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5:1991;221-231.
36. Myer V.E., Fan X.C., Steitz J.A. Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16:1997;2130-2139.